Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers

por Rasmussen, Scott, Horkan, Kathleen Halabuk, Kotler, Mitchell
Publicado 2018

Single‐Dose Bioequivalence of Two Mini Nicotine Lozenge Formulations

por Rasmussen, Scott C., Becker, William D., Shanga, Gilbert M.
Publicado 2017

Effect of bimagrumab on thigh muscle volume and composition in men with casting‐induced atrophy

por Rooks, Daniel S., Laurent, Didier, Praestgaard, Jens, Rasmussen, Scott, Bartlett, Michael, Tankó, László B.
Publicado 2017

Laying it on thick: Ecosystem effects of sediment placement on a microtidal Rhode Island salt marsh

por Raposa, Kenneth B., Bradley, Michael, Chaffee, Caitlin, Ernst, Nick, Ferguson, Wenley, Kutcher, Thomas E., McKinney, Richard A., Miller, Kenneth M., Rasmussen, Scott, Tymkiw, Elizabeth, Wigand, Cathleen
Publicado 2022

Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy Volunteers

por Ackert, Jessica, Mohamed, Khadeeja, Slakter, Jason S., El-Harazi, Sherif, Berni, Alessandro, Gevorkyan, Hakop, Hardaker, Elizabeth, Hussaini, Azra, Jones, Siôn W., Koh, Gavin C. K. W., Patel, Jyoti, Rasmussen, Scott, Kelly, Deborah S., Barañano, David E., Thompson, John T., Warren, Keith A., Sergott, Robert C., Tonkyn, John, Wolstenholme, Allen, Coleman, Hanna, Yuan, Alex, Duparc, Stephan, Green, Justin A.
Publicado 2019

Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19

por Isa, Flonza, Forleo-Neto, Eduardo, Meyer, Jonathan, Zheng, Wenjun, Rasmussen, Scott, Armas, Danielle, Oshita, Masaru, Brinson, Cynthia, Folkerth, Steven, Faria, Lori, Heirman, Ingeborg, Sarkar, Neena, Musser, Bret J., Bansal, Shikha, O'Brien, Meagan P., Turner, Kenneth C., Ganguly, Samit, Mahmood, Adnan, Dupljak, Ajla, Hooper, Andrea T., Hamilton, Jennifer D., Kim, Yunji, Kowal, Bari, Soo, Yuhwen, Geba, Gregory P., Lipsich, Leah, Braunstein, Ned, Yancopoulos, George D., Weinreich, David M., Herman, Gary A.
Publicado 2022